The Ministry of Health will do this through the Translational Medicine Research Center A study on the use of medicinal cannabis oil in the treatment of chronic migraine, The research will be carried out jointly with the ELEA laboratory and people between the ages of 18 and 65 with a history of migraine for a year or more, and those who have had 15 or more headaches per month, are willing to participate. can register.
CIMT chief Carlos Lano commented that the investigation would begin in late October; and explained that “treatment is very difficult for people who have chronic migraines.” “There is no treatment that is effective and has few adverse effects. It is a dream and hope, with cannabis oil as a potentially effective drug with few side effects,” said the professional.
Lano said that “it is very important for the Ministry of Health to approve this project and the approval of the ELEA laboratory, who relied on the protocol they submitted from the province. The laboratory will provide pharmaceutical products for the research center to study.”
In addition, the doctor indicated that “this is a huge challenge, and we have a great team made up of established professionals at Vera Barros Hospital that will begin studies to see if this pharmaceutical product is really a good fit for those people.” There may be alternatives to those who have chronic migraine”.
In 2020, the Ministry of Health created the Translational Medicine Research Center to operate at the Hospital de la Madre y El Nio and brought together professionals from departmental and capital hospitals in research and training projects.
In addition, La Rioja will this year have its first cannabis oil with its seal for medicinal use and will be distributed through a program of the Ministry of Health in accordance with those established in the regulations.